Month: <span>June 2024</span>

Home / 2024 / June
FDA panel OKs new COVID vaccine for fall
Post

FDA panel OKs new COVID vaccine for fall

JUNE 6, 2024 by Robin Foster A U.S. Food and Drug Administration advisory panel on Wednesday recommended updating the formula for COVID vaccines ahead of a fall campaign that will encourage Americans to get the latest shots. The unanimous vote recommends that vaccine makers tailor the next vaccine to target the JN.1 variant, which dominated...

Long COVID’s toll outlined in new report
Post

Long COVID’s toll outlined in new report

JUNE 6, 2024 by Robin Foster Long COVID continues to plague millions of Americans as the health costs of the pandemic linger four years later, a new report warns. In a hefty document released Wednesday, the National Academies of Sciences, Engineering and Medicine, a nongovernmental group that advises federal agencies on science and medicine, detailed...

Testing gait to help in early diagnosis of neurodegenerative disease
Post

Testing gait to help in early diagnosis of neurodegenerative disease

JUNE 7, 2024 by Deb Balzer, Mayo Clinic News Network Credit: Unsplash/CC0 Public DomainHow does your gait—or how you walk—relate to your brain health? Considerably, says Dr. Farwa Ali, a Mayo Clinic neurologist who specializes in movement disorders. Assessing a person’s gait can offer insight into various brain health conditions. The hope is that early...

Mpox is still circulating among U.S. gay men, report warns
Post

Mpox is still circulating among U.S. gay men, report warns

JUNE 7, 2024 Though not at numbers seen in the 2022 outbreak, mpox cases are still circulating in the United States, largely among gay and bisexual men, new government data shows. According to the U.S. Centers for Disease Control and Prevention, the outbreak of mpox (formerly known as monkeypox) viral illness in the United States...

Microplastics found in every semen sample tested by research team
Post

Microplastics found in every semen sample tested by research team

JUNE 7, 2024 by Bob Yirka , Medical Xpress Graphical abstract. Credit: Science of The Total Environment (2024). DOI: 10.1016/j.scitotenv.2024.173522A team of public health researchers affiliated with multiple institutions in China has found microplastics in the semen of every sample they tested. In their study, published in the journal Science of the Total Environment, the...

Post

New Oral Weight Loss Drugs: Where Are We and What’s Next?

Medscape Medical News > Features Marilynn Larkin June 05, 2024 Now that semaglutide (Wegovy), tirzepatide (Zepbound), and other injectables have created an insatiable market for weight loss drugs, biotech and pharmaceutical companies are roaring ahead with oral formulations, which promise a greater level of convenience, in line with patient preference. One particularly intriguing entry is...

Brain imaging study shows how THC in cannabis disrupts brain activity and may cause cognitive impairment
Post

Brain imaging study shows how THC in cannabis disrupts brain activity and may cause cognitive impairment

JUNE 5, 2024 by Noah Brown, Massachusetts General Hospital Resting-state functional connectivity after THC intoxication. Credit: Neuropsychopharmacology (2024). DOI: 10.1038/s41386-024-01876-5A new study led by investigators from Massachusetts General Hospital reveals that the main psychoactive component in cannabis or marijuana disrupts the normal connections and activity of the brain’s prefrontal cortex, a region that is crucial...

Post

Is Myocardial Infarction Overdiagnosed?

NEWS Dr Pierre Margent | 04 June 2024 Each year in the United States, 750,000 patients are diagnosed with myocardial infarction (MI). Far more patients are evaluated for suspected MI. The diagnosis is often considered during an emergency department visit, sometimes with atypical signs, nonspecific symptoms, or even in the absence of symptoms. Up to...

One in six people who stop antidepressants will experience discontinuation symptoms as a direct result, says study
Post

One in six people who stop antidepressants will experience discontinuation symptoms as a direct result, says study

JUNE 5, 2024 by Lancet Credit: Pixabay/CC0 Public DomainFor someone stopping taking antidepressants, the risk of experiencing one or more discontinuation symptoms (also called withdrawal symptoms), such as dizziness, headache, nausea, insomnia and irritability due directly to stopping the medication is 15% (equivalent to one in six to seven people), according to a systematic review...